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Abstract 
The role of microtubules in the control and dynamics of the IS remains unresolved. 
Here we show that T cell activation requires the growth of microtubules mediated by 
the plus-end specific protein end-binding 1 (EB1). A direct interaction of the T Cell 
Receptor (TCR) complex with EB1 provides the molecular basis for EB1 activity 
promoting TCR encounter with signaling vesicles at the IS. EB1 knockdown alters 
TCR dynamics at the IS and prevents propagation of the TCR activation signal to 
LAT, thus inhibiting activation of PLCγ1 and its localization to the IS. These results 
identify a role for EB1 interaction with the TCR in controlling TCR sorting and its 
connection with the LAT/PLCγ1 signalosome. 
 
Keywords: T cell activation, cell signaling, vesicular trafficking, cytoskeleton, 
microtubule dynamics. 
Introduction 
The TCR complex is exposed on the surface of T cells, and is formed by 
heterodimers of ligand-binding subunits, either TCR-α and TCR-β (in αβ T cells) or 
TCR-γ and TCR-δ (in γδ T cells), which associate with the signal-transducing 
subunits CD3γ, -δ, -ε and -ζ (van der Merwe & Dushek, 2011). The cytoplasmic tails 
of CD3γ, -δ, and -ε contain a single copy of a motif called ITAM (immune-receptor 
tyrosine-based activation motif), whereas CD3ζ contains three ITAMs. ITAMs are 
phosphorylated upon TCR stimulation by kinases of the src family. Phosphorylated 
ITAMs are docking sites for SH2-domain containing proteins (Schamel et al, 2006). 
ITAM phosphorylation is necessary for the polarization of the centrosome to the 
immune synapse (IS) (Lowin-Kropf et al, 1998), which is therefore dependent on Lck 
and Fyn tyrosine kinase activity (Etienne-Manneville, 2010; Lowin-Kropf et al, 1998; 
Martin-Cofreces et al, 2006). Centrosome movement is dependent on the 
dynein/dynactin motor, which allows sustained TCR activation (Martin-Cofreces et 
al, 2008) and polarized secretion (Huse et al, 2008). The movement of the centrosome 
carries cytoplasmic organelles, including the Golgi, multivesicular bodies and the 
mitochondria network, toward the IS (Calabia-Linares et al, 2011), contributing to 
TCR signaling and IS formation (Baixauli et al, 2011).  
The specific function of microtubules (MTs) in T cell activation is poorly 
understood. MTs are large polymers of α/β-tubulin dimers that control intracellular 
organelle distribution and trafficking (Etienne-Manneville, 2010). MTs show intrinsic 
polarity, with minus-ends that can anchor to the centrosome to avoid rapid de-
polymerization (Li & Gundersen, 2008). MT plus-ends show dynamic instability, 
being able to switch between growing and shrinkage phases. End-binding proteins 
(EBs) are highly conserved and ubiquitous plus-end tracking proteins (+TIP) 
(Tirnauer & Bierer, 2000). The three EBs (EB1, 2 and 3) are small dimeric proteins 
that contain an N-terminal calponin homology domain (CH) which is able to bind to 
MTs. These proteins possess, at their C-terminus, a flexible acidic tail that contains 
the sequence EEY/F, required for self-inhibition and binding to various partners, that 
can control microtubule growth (Akhmanova & Steinmetz, 2008; Manna et al, 2008).  
 In this study, EB1 was found to bind to the CD3 ITAMs. Knockdown of EB1 
in T cells prevents TCR clustering at the IS and the correct phosphorylation of LAT 
and PLCγ1. We found that EB1 regulates vesicular trafficking at the IS and therefore 
the connection between the TCR and downstream signaling molecules, such as 
LAT/PLCγ1. These results suggest that TCR-EB1 interaction may play a dual role at 
the IS, controlling both TCR sorting and its encounter with the LAT/PLCγ1 
signalosome. 
 
 
Results 
EB1 directly interacts with the CD3 ITAMs through its four-helix bundle. 
To identify new interacting partners of the TCR complex, we used a yeast two-hybrid 
SOS-recruitment system to screen for CD3ε cytoplasmic tail-binding proteins. EB1 
was identified in this screening (Supplementary Table S1). The isolated cDNA 
encodes the C-terminal third of EB1 (82 aminoacids). To confirm EB1-CD3ε 
interaction, we performed pull-down assays with GST-EB1 fusion protein in COS 
cells transfected with different CD3 subunits. CD3ε and CD3ζ, were recovered but 
not CD3γ or CD3δ (Figure 1A). GST-EB1 also co-precipitated a purified cytoplasmic 
fragment of CD3ζ (Supplementary Figure S1A), thus suggesting that EB1 interaction 
with CD3 subunits is direct.  
 ITAMs are the shared regions in the cytoplasmic tails of CD3ε and CD3ζ. 
Therefore, we assessed whether EB1 interacts with CD3ε and CD3ζ ITAMs using 
chimeric fusion proteins of CD8α with each of the three CD3ζ ITAMs (ζA, ζB and 
ζC), or the cytoplasmic tail of CD3ε. EB1 strongly co-precipitated with each of the 
three ITAMs from CD3ζ (CD8-ζC, CD8-ζA and CD8-ζB) as well as with CD8-ε, but 
not with CD8γ (Figure 1B). Therefore, the specificity for the ITAMS of CD3ζ and ε 
can be explained by the sequence of these ITAMs, which are less acidic than the 
ITAMs of CD3γ and δ (Figure 1B). 
 To characterize the CD3-binding site in EB1, we generated a panel of GST 
fusion proteins (Figure 1C). As predicted from the two-hybrid screen, CD3 bound to a 
construct, GST-Ct, which contained the C-terminal 82 amino acids of EB1. The first 
half of the α1 helix is not required for CD3 binding, since deletion of the first 10 or 
20 amino acids (a and b constructs) did not prevent the EB1-CD3 interaction. 
Likewise, the acidic tail seems to be unnecessary since deletions d and e did not affect 
the interaction. However, CD3-EB1 interaction was abrogated by simultaneous 
elimination of the acidic tail and half of the α1 helix (deletion be) or by either 
complete deletion of helix α2 or most of helix α1 (deletions f and c). These findings 
indicate that CD3 binds to the four-helix bundle of EB1. 
To analyze whether the CD3-EB1 interaction takes place in T cells, EB1 was 
immunoprecipitated from murine thymocytes and spleen T cell lysates. EB1 was 
found associated to CD3ζ in cells from both organs (Supplementary Figure S1B). To 
study whether TCR stimulation affects CD3ζ interaction with EB1, anti-CD3 
stimulated thymocytes and spleen T cells were immunoprecipitated with anti-CD3ζ. 
EB1 co-immunoprecipitated with the TCR in both cell lysates, independently of CD3 
stimulation (Figure S1C). When EB1 immunoprecipitations were carried out with 
surface-biotinylated Jurkat T cells, two major biotinylated bands were detected, 
corresponding to the CD3ζ homodimer and the TCRα/β heterodimer, together with 
weak signals for CD3γ, CD3δ and CD3ε (Figure 1D). This result points to an EB1 
association to a partial TCR complex that contains TCRαβ and CD3ζ. The effect may 
be due to a multichain immune receptor oligo-oligomerization, where the TCR and 
CD3 subunits dissociate upon stimulation (Sigalov, 2006). Alternatively, it could be 
due to a different rate of degradation for the TCR expressed on the surface, as TCRαβ 
degrades faster than CD3 chains in non-stimulated cells (San Jose & Alarcon, 1999). 
Since the association of EB1 with TCRαβ and CD3ζ is detected in non-stimulated T 
cells (Fig. 1D), this interaction may be involved in the trafficking of the most rapidly-
degraded TCR subunits from the plasma membrane.  
To further analyze whether EB1 binding to CD3ζ was altered by stimulation, 
CD3ζ was immunoprecipitated from primary CD8+ OT-I transgenic T cells 
stimulated by OVA antigen-loaded T2kb cells. The recovery of EB1 was similar with 
or without stimulation (Figure S1D). Moreover, in the mouse T cell hybridoma 2B4, 
stimulation with anti-CD3ε+CD28 antibodies did not increase the association of EB1 
with the TCR. Effective stimulation in these assays was confirmed by reprobing the 
membrane with a phosphospecific antibody, revealing that TCR triggering induced a 
clear increase in the tyrosine phosphorylation of CD3ζ (Figure S1E). Finally, CD3ζ 
homodimer was co-precipitated by EB1 immunoprecipitation in CH7C17 T cells 
activated or not with HA antigen (Figure 1E). These results indicate that EB1 
interacts constitutively with the TCR in T cells, independently of their 
phosphorylation state. 
EB1 localizes at the plus-ends of microtubules in the immune synapse. 
The localization of EB1 during immune synapse formation in activated T cells 
was assessed in a model of antigen-specific presentation. Primary CD4+ T cells from 
OT-II transgenic mice were isolated and conjugated with TNF-α–activated, bone 
marrow-derived dendritic cells (DCs). In these conjugates, T cells are observed as 
small, round cells. Cell morphology and IS formation were monitored by F-actin 
staining. EB1 was detected at the tips of MTs in both the T cell and the DC. In the 
OVA-stimulated T cells, EB1 strongly decorated the ends of MT emerging from the 
polarized MTOC (yellow arrow, Figure 2A and Supplementary Figure S2A), being 
closely apposed to the cortical F-actin at the IS. This localization suggests a possible 
role of highly EB1-enriched MT plus-ends as docking structures for maintaining the 
MTOC at the IS. To further assess EB1 localization during IS formation, we 
conjugated human polyclonal, primary T lymphoblasts with either control or SEE-
pulsed Raji B cells (antigen-presenting cell, APC; Figure 2B). In the absence of SEE, 
T lymphoblasts localize their MTOC at the uropod (U). In this condition, endogenous 
EB1 was clearly observed both at the MTOC (yellow arrow) and at points that 
correspond to the ends of microtubules (white arrowheads). The confocal plane 
shown for SEE-stimulated conjugates reveals the polarized MTOC localized at the IS. 
The points of EB1 staining can be observed near the CD3ζ cluster. The 3D 
reconstructions of the boxed areas in merged images allow observation of different 
planes, from the internal MTOC area to the zone just beneath the plasma membrane, 
marked by CD3ζ. Points of EB1 staining are observed in all planes, co-localizing with 
CD3ζ-enriched intracellular clusters and partially co-localizing with CD3ζ in the 
more external planes of the 3D reconstruction (white arrows, right panels in Figure 
2B).  
We further analyzed EB1 localization during IS formation in centrosomes 
isolated by fractionation through sucrose gradients. GCP3 protein was used as a 
specific marker of centrosomal fractions (Bettencourt-Dias & Glover, 2007). 
Equivalent volumes of specific fractions were loaded on the gel, revealing an 
increased content of EB1 protein in the centrosomal fractions of activated T 
lymphocytes (Figure 2C). EB1 at the centrosome is essential to configure a radial 
array of microtubules (Askham et al, 2002). Indeed, the increase of EB1 in the 
centrosomal fractions points to an increase in the polymerization of microtubules 
from the centrosome. Therefore, EB1 localization in the plus-ends of microtubules 
and in the centrosome upon T cell activation suggest a role for EB1 in the regulation 
of microtubule dynamics at the IS. 
EB1 guides microtubule dynamics at the immune synapse. 
To explore the role of EB1 as a plus-end tracking protein at the IS, we 
analyzed whether MTs are actively polymerized at the IS. Growth of MTs from the 
polarized MTOC was detected in antigen-specific cell conjugates of CH7C17 Jurkat 
cells and HA-pulsed APCs using EB1-GFP, at imaging the confocal plane where the 
MTOC localized at the interface with the APC (Figure 3A; Supplementary Movie 
S1). EB1-GFP has been previously used to enable tracking of MT growth by TIRF 
microscopy (Grigoriev & Akhmanova, 2010) during T cell spreading over an 
activating anti-CD3+anti-CD28 surface (Bunnell et al, 2001). In this system, the EB1-
GFP-labeled MT plus tips appear very soon after cells make contact with the surface, 
and MTOC polarization (white arrow in Figure 3B; Supplementary Movie S2) is 
visualized within minutes. EB1-GFP is observed at the MTOC co-localizing with 
tubulin-Cherry rapidly upon T cell spreading (Supplementary Figure S2B). The 
irradiation of MTs is observed as points of EB1-GFP emanating from the translocated 
MTOC (Figure 3B; white arrows in Figure 3C; Supplementary Figure S2B and Movie 
S2-3). MTs can be visualized as filaments upon maximal projection of the time 
sequence on the XY plane (2D + t’, Figure 3B-C). MT growth is also observed at the 
cell periphery during spreading, with some EB1-marked tips surrounding the adhesion 
area (red arrows in Figure 3B; Supplementary Movie S2) and even crossing over the 
central area (yellow arrow in Figure 3B; Supplementary Movie S2). These results 
point to MTOC polarization as a mechanism for facilitating EB1-driven 
polymerization of MTs at the IS, providing a dynamic meshwork for intracellular 
transport.  
To analyze the relationship between MT dynamics and intracellular transport, 
CD3ζ dynamics was tracked with CD3ζ-Cherry, which was found both in 
microclusters attached to the activating surface and in vesicles (Supplementary Figure 
S3 and Movie S3). EB1-GFP and CD3ζ-Cherry are observed at the cell surface 
during spreading and CD3ζ-Cherry signal increases at a central cluster corresponding 
to the later localization of the polarized MTOC (Figure 3C and Supplementary Movie 
S4). When using a penetrance depth of 90 nm in TIRFM, microclusters are mainly 
observed, whereas at 110 nm vesicles are also imaged (Figure 3C, Supplementary 
Figure S3 and Movie S3 and 4) and for a penetrance depth of 150 nm, vesicles were 
mainly on the focus plane (Figure 3D, Supplementary Movie S5). CD3ζ+ vesicles co-
localized with the EB1-marked MT tips during T cell spreading over the activating 
surface (Figure 3D). These vesicles entered and exited the TIRF focal plane at sites of 
active MT growth (yellow and white arrowheads, respectively). These results indicate 
that CD3+ vesicles preferentially use the observed areas of high MT dynamics to 
move and accumulate.  
EB1 controls the movement of CD3ζ-Cherry-containing vesicles at the IS. 
To assess the function of EB1 in the movement of the CD3ζ-Cherry-enriched 
vesicles, EB1 was specifically knocked-down in CH7C17 T cells (Supplementary 
Figure S4). Tracking of vesicle movement by TIRFM in cells plated on stimulating 
surfaces revealed that movement of CD3ζ-Cherry vesicles at the central area of the T 
cell was impaired in EB1-depleted cells and that these vesicles were mostly displaced 
to the periphery (Figure 4A and Supplementary Movie S6). This is illustrated by 
projecting the time lapse on the XY plane (2D + t’), which details the areas where the 
CD3ζ+ vesicles have been moving (Figure 4B). The time projection on Figure 4C 
shows that the trajectories of the vesicles in EB1-silenced cells were irregular, in 
contrast with control cells. Therefore, these data indicate an EB1-dependent, specific 
control of CD3ζ vesicle movement at the IS. To further analyze the role of EB1 in 
CD3ζ positioning at the IS, EB1 expression was silenced in SEE-specific human T 
lymphoblasts and J77 Jurkat cells (Supplementary Figure S4B-C). Cell conjugates 
were formed with SEE-pulsed APCs, and analyzed for CD3ζ accumulation at the IS. 
Although in EB1-depleted cells CD3ζ can be found at the contact area with the APC 
(Supplementary Figure S5), its clustering at the central area of the IS is impaired 
(Figure 4D; Supplementary Figure S5). Hence, CD3ζ was found at the periphery of 
the contact area, correlating with the observed trajectories of the vesicles in EB1-
silenced cells. Indeed, the mean fluorescence intensity per area at the IS was 
decreased in EB1-silenced cells (Figure 4D). 
EB1 regulates the interaction of the TCR and LAT/PLCγ1 signalosomes. 
To further analyze CD3ζ behaviour at the IS, we used TIRF microscopy to 
analyse the movement of GFP-tagged LAT-enriched vesicles in control and EB1-
silenced cells. When EB1 expression is reduced, the movement of LAT-GFP vesicles 
at the contact area with the activating surface is impaired (Figure 5A; Supplementary 
Movie S7-8). In control T cells LAT-GFP and CD3ζ-Cherry-enriched vesicles co-
localized upon plating on the activating surface, but this was not seen in EB1-silenced 
cells (Figure 5B; Supplementary Figure S6 and Supplementary Movie S9-10). The 
analysis of the movement of vesicles that appear and disappear form the TIRF plane 
showed that not only vesicle encounter is reduced, but that their movement is less 
organized, as observed in the 3D reconstruction of XY planes and time frames (Figure 
5B). Analysis of LAT in EB1-silenced T lymphoblasts revealed that LAT did not 
accumulate at the uropod as in control cells, which relates to the increase in the LAT 
accumulation at the cell-cell contact in non-stimulated conjugates (Supplementary 
Figure S7). Upon stimulation with SEE-pulsed APCs, LAT accumulation at the IS 
area was decreased in EB1-silenced cells, but not abrogated. Indeed, the relative 
fluorescence intensity of LAT in EB1-silenced cells was also reduced with respect to 
control cells, suggesting that the redistribution of LAT from intracellular 
compartments is poorly achieved in EB1 silenced cells (Supplementary Figure S7A-
B). The relationship between CD3 and LAT was further explored through specific 
immunoprecipitation of CD3ζ in control T cells or EB1-silenced T cells (Figure 5C). 
Using specific conditions to preserve the microtubular cytoskeleton upon cell lysis, 
we have observed a decrease in the LAT recovery with CD3ζ upon EB1 silencing. 
These results point to a role of EB1 in the organization of the IS. To analyze the 
activation state of T cells upon EB1 silencing, we analyzed the phosphorylation of the 
scaffold molecule LAT. Phosphorylation of LAT on residues Y132 and Y191 was 
impaired in EB1-silenced T cells upon activation with HA and SEE, compared with 
the level in control cells (Figure 6A). In contrast, the phosphorylation level of CD3ζ 
(Y83) and ZAP70 (Y493) in response to Ag (HA) or SEE activation was unaffected 
(Figure 6B-C). Stimulation of EB1-silenced T lymphoblasts with anti-CD3+anti-
CD28 yielded similar results (Figure 6D). Signal propagation from the stimulated 
TCR to LAT thus seems to be prevented when EB1 is absent.  
As a further test of the role of EB1 in T cell activation we examined the 
activation of PLCγ1 at the IS by confocal microscopy of T-APC conjugates. PLCγ1 
activation was determined by monitoring phosphorylation of residue Y783 (Poulin et 
al, 2005). Activated PLCγ1 was clearly localized at the IS of control T lymphoblasts, 
but this accumulation was prevented by EB1 depletion (Figure 7A-B). This finding 
was corroborated by analysis of the timing of PLCγ1 phosphorylation upon TCR 
activation, which showed that the activation of PLCγ1 is defective in these cells 
(Figure 7C). This result correlates with the lack of phosphorylation of LAT at Y132 
(Figure 6A and D), where PLCγ1 docks upon stimulation (Paz et al, 2001). These 
results support a role for EB1 in connecting the TCR and LAT signalosomes to allow 
signal propagation during T cell activation. 
Discussion. 
In this study, we report the role of the +TIP microtubule-associated protein 
EB1 in IS formation and T cell activation in cells of human and mouse origin. We 
identify a new function for EB1 in connecting the trajectories of signaling vesicles at 
the IS, allowing coordinated transfer of the activation signal from the TCR to the LAT 
signalosomes. 
The microtubule network organized around the MTOC has historically been 
viewed as a static scaffold for vesicle movement in polarized secretion (Stinchcombe 
& Griffiths, 2007) or for specific signaling microclusters at the IS (Hashimoto-Tane et 
al; Lasserre et al, 2010). The microtubule network was also found to be important for 
maintaining the contact area of T cells with a stimulating surface (Bunnell et al, 
2001). The dynamics of the tubulin cytoskeleton has been analyzed in T cells in terms 
of post-translational modifications, particularly acetylation of lysine 40 in the α-
tubulin subunit, which marks a population of more stable microtubules (Serrador et al, 
2004). Over-expression of histone-deacetylase 6 (HDAC6), which deacetylates 
acetylated α-tubulin, prevents localization of the TCR at the center of the IS and the 
translocation of the microtubule-organizing center (MTOC). CD3ζ (Serrador et al, 
2004) and ZAP70 (Huby et al, 1995) signaling components of the TCR complex have 
been shown to associate with α-tubulin upon TCR stimulation, and this is prevented 
by chemical inhibition of HDAC6 (Serrador et al, 2004). A specific relationship is 
thus established between tubulin and the TCR complex during T cell activation. 
However, the specific growth of microtubules at the IS and the role of this process has 
not been addressed previously. We detected active and specific tubulin 
polymerization at the IS, paralleling the localized polymerization of actin (Gomez & 
Billadeau, 2008). Our data show that the centrosome of the activated T lymphocyte is 
very active as a centre of tubulin polymerization (MTOC) upon TCR engagement, 
and its translocation to the IS facilitates the localization of newly polymerized 
microtubules to this active cellular location. These microtubules may serve to guide 
the trafficking of specific vesicles at the IS to the plasma membrane and from the 
plasma membrane to intracellular compartments since inhibition of MT growth 
through specific knock-down of EB1 (Komarova et al, 2009), prevents the correct 
movement of vesicles. Other foci of MT growth, unrelated to the centrosome and the 
Golgi Apparatus (Vinogradova et al, 2009), may contribute to intracellular traffic at 
the IS and further studies should elucidate their role. 
EB1 is composed of two well-differentiated domains: a globular calponin-
homology domain that encompasses the N-terminal half of the protein and binds to 
MTs, and a C-terminal homodimerization domain. In the EB1 homodimer, the C-
terminal domain adopts a novel coiled-coil, four-helix bundle conformation. Our 
results show that EB1 interacts through this four-helix bundle domain with the ITAM 
of CD3ε and the ITAMs of CD3ζ. This interaction may underlie the ability of EB1-
decorated MT plus ends to bind TCR-bearing vesicles, promoting their movement in 
and out of the IS-plane. Interestingly, the movement of the vesicles is erratic when 
EB1 expression is reduced, and corresponds to the localization of accumulated, 
peripheral clusters of TCR in fixed cell conjugates. 
Our results reveal that signals from the TCR signalosome (Guy & Vignali, 
2009) cannot propagate to the LAT/PLCγ1 cassette when EB1-dependent tracking of 
microtubules is disrupted, supporting the notion that a continuously-remodeled 
microtubular network is essential for the trafficking of vesicles at the IS. Moreover, 
TCR and LAT vesicles appear to be different and must encounter each other to allow 
the specific propagation of activation signals. These effects are very rapid and can be 
observed readily after T cell activation, correlating with the described effect of 
HDAC6 on tubulin dynamics upon TCR engagement (Serrador et al, 2004). The 
backward trafficking to intracellular compartments of vesicles docked at microtubule 
plus-tips is in accord with a recently proposed model (Akhmanova & Hammer, 2010), 
in which dynein/dynactin molecular motors would drive movement toward the minus 
end of the microtubules (the centrosome). In this regard, EB1 C terminus ends with an 
acidic stretch that has been described as the binding site for p150Glued, a dynactin 
subunit (Manna et al, 2008). Therefore, EB1 localized at microtubule plus-ends may 
help the interaction of TCR and thus CD3ζ-enriched vesicles with dynein/dynactin 
motors. A dynein/dynactin-driven movement would promote the movement of 
vesicles along microtubules toward their minus-end, the centrosome, where the Golgi 
is organized. The multivesicular bodies found at the IS (Calabia-Linares et al, 2011; 
Mittelbrunn et al, 2011) might also be the fate of the TCR-containing vesicles, on 
their way to recycling or degradation pathways. Early endosomal compartments may 
also be attained through microtubule driven trafficking (Nielsen et al, 1999). 
The failure of MTOC translocation in dynein/dynactin-disrupted T cells of 
human origin (Martin-Cofreces et al, 2008) would prevent the tubulin polymerization 
at the IS observed here, preventing correct movement of vesicles toward intracellular 
compartments. The predicted outcome would be accumulation of TCR at the 
periphery of the IS instead of forming a central cluster, as observed (Martin-Cofreces 
et al, 2008). The tubulin cytoskeleton and related proteins therefore appear to be of 
critical importance for the formation of the IS and sustained T cell activation. In this 
regard, a recent report has identified casein kinase I δ (CKIδ) as an important kinase 
controlling MTOC translocation to the IS and microtubule growing. CKIδ can bind to 
EB1 and the region of CKIδ implicated in this interaction is required for MTOC 
translocation (Zyss et al, 2011). Therefore, EB1 localization at the MTOC may be 
determined by CKIδ, and its plus-end tracking activity regulated by the kinase 
through phosphorylation to promote the microtubule growing observed herein. 
However, the lack of CKIδ does not affect IS architecture nor signaling (Zyss et al, 
2011), which points to other complementary mechanisms to regulate EB1 function. 
We found that vesicle movement is important for correct activation of 
signaling via LAT and PLCγ1. Phosphorylation of these proteins on key residues was 
decreased in EB1-silenced cells, even though the rate of phosphorylation of CD3ζ and 
ZAP70 was similar to control cells. LAT phosphorylation during T cell spreading and 
its correspondence with microclusters has been shown to be relevant during T cell 
activation (Campi et al, 2005). Indeed, the relative movement of LAT microclusters 
with respect to LAT vesicles has also been shown to be important for correct T cell 
activation (Purbhoo et al, 2010). Our results show that the coordinated movement and 
correct encounter between CD3ζ- and LAT-enriched vesicles is necessary for signal 
propagation from the TCR. This movement may help the relationship between the 
described protein islands for TCR and LAT (Lillemeier et al, 2010). The specific 
contribution of MTOC translocation to the localization of vesicles at the IS and 
subsequent microtubule polymerization warrants further research. 
Material and Methods. 
Cells, plasmids and cell transfection. All primary healthy donor samples were 
obtained after written consent, in accordance with the Declaration of Helsinki, and 
approved by the Hospital La Princesa Research Ethics Committee. Human T 
lymphoblasts were obtained from peripheral blood lymphocytes (PBLs) isolated from 
freshly prepared buffy coats. Buffy coats were subjected to gradient centrifugation on 
Histopaque-1077 from Sigma-Aldrich (St. Louis, MO, USA), followed by 2 rounds of 
plastic adherence. SEE-specific human T lymphoblasts were obtained as described 
(Ibiza et al, 2006). Vβ8+ Jurkat T cell clones (J77) and the lymphoblastoid Raji and 
Hom2 B cell lines were cultured in complete medium. HA-specific, Vβ3+ Jurkat T 
cells (CH7C17) were supplemented with 400 µg/ml hygromycin B and 4 µg/ml 
puromycin (Martin-Cofreces et al, 2008). T lymphoblasts were isolated by negative 
selection using the AutoMACS cell separation system (Miltenyi Biotec GmbH, 
Bergisch Gladbach, Germany). The cDNA encoding N-terminal GFP-linked EB1 was 
a kind gift from Anna Akhmanova (Utrecht University, The Netherlands). LAT-GFP 
was as described (Bonello et al, 2004). The indicated cDNAs were transiently 
transfected into T cells (2x107) with the Bio-Rad Gene Pulser II electroporation 
system. At 16 h post-transfection, viable T lymphoblasts, J77 or CH7C17 cells were 
isolated by centrifugation on a Ficoll-Hypaque gradient and conjugated with Raji (T 
lymphoblasts and J77 cells) or Hom2 cells (CH7C17 cells) for functional studies. EB1 
silencing assays were performed as follows: J77 or CH7C17 T cells were 
electroporated with a shRNA plasmid encoding a specific 21 bp sequence against 
EB1 (GACATGACATGCTGGCCTGCG) or with the corresponding control plasmid 
encoding a negative sequence (TGGCATTGTCTTACCGCCTAT) (Genscript, 
Piscataway, NJ, USA), or instead with a double-stranded control siRNA or a specific 
sequence against EB1 (CAGACAAGGUCAAGAAACU and 
CGUACGCGGAAUACUUCGA, respectively; Eurogentec, San Diego, CA, USA) at 
a final concentration of 2 µM per sample. Cells were then collected and the efficiency 
of gene silencing assessed by western blot. Cells were used for experiments on day 
three post-electroporation with shRNA or the day after electroporation with siRNA. 
For TIRFM analyses, cells were re-electroporated with shRNA and plasmids for 
LAT-GFP and/or CD3ζ-Cherry after 3 days of cell culture with 0.75 mg/ml G418 as 
selection antibiotic and used the following day. 
Yeast two-Hybrid assay.  
To characterize new CD3ε-interacting partners we used the yeast two-hybrid SOS-
recruitment system (Gil et al, 2002). The sequence encoding the human CD3e 
cytoplasmic tail was amplified by PCR with end primers that add NcoI and SacI 
flanking restriction sites, and was cloned into the plasmid pSOS (Stratagene) to yield 
pSOS-CD3ε. As a bait we used the construct pSOS-CD3ε Tandem containing two 
copies in tandem, head to tail, of the cytoplasmic tail of CD3ε. The control constructs 
pSOS-Mafb, pMyr-Mafb and pMyr-LamC were provided by Stratagene. The bait 
construct was transfected in the cdc25 yeast mutant together with a human spleen 
cDNA library made in the pMyr vector (Stratagene) and the transfectants (3x106) 
were selected at the restrictive temperature (37ºC) in a manner dependent of 
galactose, and not glucose, as a carbon source. Of the 319 resulting colonies, 304 
were discarded as revertants of the cdc25 mutation since they grew in the 
presence of glucose. The pMyr plasmid was isolated of the remaining 15 clones 
and assayed in regard to their ability to promote the growth in galactose at 37ºC 
in the presence of the empty pSOS vector. Only two clones did not grow in these 
conditions, one contained a cDNA encoding for Nck-β (Gil et al, 2002); the other 
for the last 82 amino acids of EB1. 
Antibodies and reagents. T3b (anti-human-CD3) and was produced in the 
laboratory. Rabbit polyclonal Ab 448 (anti-human-CD3ζ) has been described 
previously (San Jose et al, 1998). Anti–human Vβ8 was from BD 
Biosciences/Clontech (San Jose, CA, USA). Unconjugated and FITC-conjugated 
anti–α-tubulin, phalloidin and GCP3 rabbit polyclonal were from Sigma-Aldrich 
(St. Louis, MO). Anti-LAT was from Santa Cruz Biotechnology, Inc. (Santa Cruz, 
CA, USA). Anti–phospho-LAT (Y191) was from Millipore (Billerica, MA, USA), and 
anti–phospho-LAT (Y132) was from Abcam (Cambridge, MA, USA). Anti–
phospho-PLCγ-1 (Y783), anti–PLCγ-1 and anti–phospho-PKCθ (T538) were from 
Cell Signaling Technology (Danvers, MA, USA). Anti-phospho-CD3z (Y83) was 
from Epitomics (Burlingame, CA, USA).  
Human fibronectin and poly-L-lysine (PLL) were from Sigma-Aldrich, SEE from 
Toxin Technology (Sarasota, FL, USA), puromycin from InvivoGen (San Diego, CA, 
USA), and hygromycin B from Roche Diagnostics GmbH (Penzberg, Germany). 
Anti-Erk 1/2 and the fluorescent secondary antibodies (Alexa 568 and 647, and 
rhodamine red X) and cell trackers (7-amino-4-chloromethylcoumarin [CMAC], 5-
(and-6)-(((4-chloromethyl) benzoyl) amino ) tetramethylrhodamine [CMTMR]) were 
obtained from Invitrogen (Carlsbad, CA, USA). Propidium Iodide was from Sigma-
Aldrich. All other reagents were of the purest grade available.  
Cell conjugate formation and immunofluorescence analysis. Raji B cells were 
loaded with the blue fluorescent cell tracker CMAC. Cells were then incubated in 
HBSS for 30 min with or without 0.5 µg/ml SEE, centrifuged at low speed, and 
allowed to form conjugates with J77 Jurkat cells or SEE-CD4 human primary T cells 
during incubation for 20 min at 37°C. Hom2 cells were also loaded with CMAC, 
incubated for 2 h with 50 µg/ml HA peptide, and allowed to form conjugates with 
CH7C17 cells. In these assays, the T cells (2X105) were mixed with an equal number 
of APCs in a final volume of 80 µl, gently resuspended, and plated onto slides coated 
with PLL (Jurkat) or FN (CH7C17). Cells were fixed with a mix of paraformaldehyde 
and methanol for 4 min at -20 ºC and permeabilized when needed for 5 min in 2% 
paraformaldehyde and 0.2% Triton X-100 in PHEM/sacarose, blocked and stained 
with the indicated Abs. Stained cells were mounted in a mowiol-based mounting 
solution (ProLong Gold antifade reagent; Invitrogen) and observed under a confocal 
laser scanning unit (TCS SP5; Leica) attached to an inverted epifluorescence 
microscope (DMI6000; Leica) fitted with an HCX PL APO 63X/1.40-0.6 oil 
objective. Images were acquired and processed with accompanying confocal software 
(LCS; Leica) or WCIF ImageJ (http://rsbweb.nih.gov/ij/). 3D analysis and maximal 
projections of the T cell–APC contact area were generated with ImageJ to obtain a z 
stack projection. Figures were composed with Photoshop CS4. 
Analysis of CD3ζ, LAT and PLCγ1 accumulation at the T-APC contact area. T-
APC conjugates were formed, fixed and analyzed by confocal imaging as indicated 
above and images were analyzed with ImageJ. We assumed that protein accumulation 
was homogeneous in the APC when present, with no additional accumulation at the 
contact zone with the T cell. For quantification in individual ISs we used a home-
made plugin for ImageJ (http://rsbweb.nih.gov/ij/) called “Synapse Measures”. By 
comparing fluorescence signals from multiple regions of the T cell, APC, IS, and 
background fluorescence, the program yields accurate measurements of localized 
immunofluorescence. A detailed description of Synapse Measures, including the 
algorithms used, is described (Calabia-Linares et al, 2011). 
Time-lapse fluorescence confocal microscopy and total internal reflection 
fluorescence microscopy (TIRFM). Raji APCs (5x105; SEE-pulsed or unpulsed) 
were allowed to adhere to FN coated coverslips in Attofluor open chambers 
(Invitrogen) at 37ºC in a 5% CO2 atmosphere. The cells were maintained in 1 ml 
HBSS (2% BSA). T cells were added (1:1 ratio) and a series of fluorescence and 
differential interference contrast frames were captured using a TCS SP5 confocal 
laser scanning unit attached to an inverted epifluorescence microscope (DMI6000) 
fitted with an HCX PL APO 63x/1.40-0.6 oil objective. Images were acquired and 
processed with the accompanying confocal software (LCS; Leica). Premiere 6.0 
software (Adobe) was used to generate QuickTime videos (Apple). 
For TIRFM, T cells transfected with CD3ζ-Cherry, LAT-GFP, and control or 
shEB1 plasmid were allowed to settle onto CD3 plus CD28 coated glass bottomed 
microwell dishes, No 1.5 (Mattek; Ashland, MA, US). Recording was initiated 3 
minutes after cells were platted and cells were visualized with a Leica AM TIRF MC 
M mounted on a Leica DMI 6000B microscope coupled to an Andor-DU8285_VP-
4094 camera. Images were acquired with a HCX PL APO 100.0x1.46 OIL objective 
and processed with the accompanying confocal software (LCS; Leica). For vesicle 
tracking, penetrance was 150 or 250 nm for both laser channels (488 and 561 nm) 
with same objective angle. Synchronization was performed through the Leica 
software.  
GST-pull down, immunoprecipitation, centrosomal isolation and 
immunoblotting. For GST-pull down, corresponding recombinant GST-protein were 
added to cell lysates and pull down performed as described (Urzainqui et al, 2002). 
For immunoprecipitation, T cells were stimulated with corresponding Ag or Sag-
pulsed APCs (ratio 1:5) or antibodies (anti-CD3 or anti-CD3 + anti-CD28) for the 
indicated times and lysed in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl buffer 
containing 1% Brj96 and phosphatase and protease inhibitors in non-reducing 
conditions. Anti-HA tag antibody, anti-CD3ζ rabbit anti-serum or anti-EB1 antibody 
were used for immunoprecipitation. For LAT and CD3ζ co-immunoprecipitation, 
cells were silenced for EB1 and stimulated or not with anti-(CD3ε+CD28) antibody-
coated beads. The complete procedure was performed at room temperature. Cells 
were lysed on PHEM buffer (60 mM PIPES, 25 mM Hepes, 5 mM EGTA, 2 mM 
MgCl2) with 0.33% Brij 96v supplemented with protease and phosphatase inhibitors. 
Preclearing and antibody recovery was performed using the Protein-G magnet beads 
from Millipore. Anti-CD3ζ rabbit anti-serum was used for immunoprecipitation 
during 2 h. Blots were revealed using True Blot reagent for detection of primary 
antibodies. Centrosomal isolation was performed from control or anti-CD3-stimulated 
CH7C17 T cells as described (Bornens & Moudjou, 1999). For analysis of protein 
phosphorylation during formation of the IS, Raji or Hom2 cells (1 × 106) were 
preloaded with 0.5 µg/ml SEE or 50 µg/ml HA peptide at 37°C for 30 min or 2 h and 
mixed with 5 x 106 Jurkat or CH7C17 cells at 37°C, respectively. After incubation, 
cells were lysed at 4°C for 40 min in 50 mM Tris-HCl, pH 7.5, containing 1% NP-40, 
0.2% Triton X-100, 150 mM NaCl, and phosphatase and protease inhibitors. Cell 
lysates were spun at 2500 g for 10 min to remove cell debris and nuclei. GST-pull 
downs, immunoprecipitates, centrosomal fractions and whole lysates were analyzed 
by SDS-PAGE, transferred to nitrocellulose membranes, and probed with the 
indicated antibodies in TBS–Tween 20. Bound antibodies were reacted with HRP 
secondary antibodies, and membranes were developed by enhanced 
chemiluminescence with SuperSignal West Pico or Femto chemiluminescent 
substrate (Pierce). Densitometric analyses were performed with ImageGauge 3.46 
software (Fujifilm).  
Statistical analysis. Data were tested for normality using the D’Agostino-Pearson 
omnibus normality test, or the Kolmogorov-Smirnov test when the sample was small. 
Differences between means were tested by Student’s t test for normal data, while non-
normal data were analyzed by the Mann-Whitney test. Two-tailed ANOVA was used 
for grouped data, followed by Bonferroni posttest. GraphPad Prism software was used 
for statistical analyses. 
Online Supplemental material. Videos 1 to 10, related to the main figures or the 
corresponding supplemental figures in the manuscript are available on-line. Videos 1-
2 reflects EB1 localization at the immunological synapse. Videos 3-6, relationship 
between EB1 and CD3. Videos 7-8, relationship between EB1 and LAT. Videos 9-10, 
correlation between LAT and CD3 vesicles depending on EB1 presence. 
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Figure Legends. 
 
Figure 1. ITAM-dependent interaction of CD3 with EB1. (A), Pull-down of HA-
tagged CD3 subunits with full-length GST-EB1 in co-transfected COS cells. A 
representative experiment out of 3 independent experiments is shown. (B) Co-
immunoprecipitation of HA-tagged, full-length EB1 with chimeras of the CD8a 
extracellular region and the depicted CD3 ITAM sequences. A representative 
experiment out of 3 independent experiments is shown. (C) Pull down with the 
depicted GST-EB1 C-terminal regions of CD3ζ from the 2B4 mouse T cell 
hybridoma and human Jurkat T cell lines. A representative experiment out of 5 
independent experiments is shown. (D) Co-immunoprecipitation of EB1 and surface 
TcR/CD3 in Jurkat T cells. Biotinylated cells were lysed and subjected to 
immunoprecipitation with anti-EB1 or CD3ζ antibodies. Samples were analyzed in 
the same gel. The image shown in the figure is a composition from two 
autoradiographs of different time exposure. (E) Co-immunoprecipitation of EB1 
with anti-CD3ζ in the human CH7C17 T cell line stimulated as indicated with HA-
pulsed Hom2 cells (ratio 10:1) in non-reducing conditions; C-, immunoprecipitation 
with control antibody. A representative experiment out of 4 independent experiments 
is shown. 
 
Figure 2. EB1 localizes at the plus-end tips of microtubules in the IS. (A) 
Conjugates formed between primary mouse CD4+ T cells from OT-II transgenic mice 
and TNF-α–stimulated, bone marrow-derived dendritic cells (DC). DCs were pulsed 
with peptide (OVA) or not (-). After incubation for 30 minutes, conjugates were fixed 
and stained for the indicated antibodies. Left panels show DIC images (DC blue-
stained with CMAC) and F actin staining. Bar, 10µm. Main panels, a single confocal 
plane from a Z-stack corresponding to the boxed area in the DIC image. Right panels, 
orthogonal projections of the indicated MTOCs (dashed lines). Representative cell 
conjugates from out of 4 independent experiments is shown. (B) Fluorescence images 
from a magnification of the conjugate boxed in the DIC image. Raji APC in blue; 
DIC, bright field image; U, uropod. Bar, 10µm. Upper panels show maximal 
projections of a confocal Z-stack showing a SEE-specific T lymphoblast conjugated 
with a control Raji APC (No SEE). Yellow arrow, MTOC; white arrowheads, 
microtubule tips. Lower panels show confocal planes from a Z-stack of stimulated T 
lymphoblasts showing their polarized MTOCs at the contact area with the APC (SEE-
pulsed Raji B cells). After incubation for 30 minutes, conjugates were fixed and 
immunostained for α-tubulin (magenta), EB1 (red) and CD3 (green). Right panels 
show 3D reconstructions of boxed area in the merged image. The resulting planes are 
ordered from the T cell intracellular region (the MTOC in the case of the SEE-
stimulated cell) toward the T cell plasma membrane in close contact with the APC. 
White arrows, co-localization of EB1 and CD3ζ. Representative cell conjugates from 
out of at least 3 independent experiments are shown. (C) Sucrose gradient 
fractionation of centrosomes (GCP3 positive fractions) showing EB1 enrichment in 
anti-CD3 stimulated T cells. Right panel shows the protein content from cell extracts. 
TL, total lysates; Cyt, cytosolic lysates; SC, sucrose cushion. Left panel shows the 
isolation of centrosomes. F, sucrose fractions. A representative experiment out of 3 
independent experiments is shown. 
 
Figure 3. Microtubule dynamics are driven by EB1 at the IS. (A) EB1-GFP–
expressing CH7C17 T cells were conjugated with HA-pulsed APCs and tracked by 
confocal fluorescence microscopy. A single confocal plane is shown. Images were 
taken every 2 s. The merged image at the right shows DIC and GFP fluorescence 
(green). *, HA-loaded Hom2 B cell. A representative cell conjugate from out of at 
least 3 independent experiments is shown. (B) EB1-GFP–expressing CH7C17 cells 
were allowed to settle on anti-CD3 plus anti-CD28 coated glass-bottomed chambers 
and images were taken every 500 ms by TIRF microscopy at a penetrance of 150 nm. 
A representative cell from out of 3 independent experiments is shown. (C) Jurkat T 
cells expressing EB1-mGFP (green) and CD3ζ-mCherry (red) were treated as in b 
and analyzed by TIRFM. Images were taken every 99 ms at a penetrance of 90 nm. 
White arrow, centrosome. Bar, 5 µm. A representative cell from out of at least 3 
independent experiments is shown. (D) Jurkat T cells co-expressing EB1-GFP (green) 
and CD3ζ-Cherry (red) were plated on anti-CD3 plus anti-CD28 coated glass-
bottomed chambers and analyzed by TIRFM. Images were taken every 1 s at a 
penetrance of 150 nm. The central panel shows magnified views of a time-lapse 
sequence of the boxed region between 1 s (left) and 40 s (right). Yellow arrowheads: 
vesicles appearing at the TRIF plane. White arrowheads: vesicles disappearing from 
the TIRF plane. White arrows: CD3ζ microclusters. 
 
Figure 4. EB1 regulates the trafficking of CD3ζ-bearing vesicles at the IS. (A) 
shRNA-transfected (control or EB1) Jurkat T cells expressing CD3ζ-Cherry were 
plated on anti-CD3 plus anti-CD28 coated glass-bottomed chambers and analyzed by 
TIRFM. Images were taken every 500 ms at a penetrance of 110 nm. A representative 
cell out of at least 4 independent experiments is shown. (B) Maximal Z projections of 
the time-lapse sequences, summarizing vesicle movement in the XY plane (2D + t’). 
(C) Trajectory characteristics are revealed by the maximal projection of the X plane 
on tY plane. (D) Images showing a single confocal plane (IS plane) corresponding to 
control (upper panel) or EB1-silenced (EB1 KD, lower panel) T lymphoblasts 
conjugated with SEE-pulsed Raji cells. Cells were mixed and cultured for 30 minutes, 
fixed and stained with the indicated antibodies. The graph to the right plots the 
distribution of intensity/area of CD3ζ at the IS. Data are means +/- SD from 3 
independent experiments. (P, Mann-Whitney test). 
 
Figure 5. Signal propagation at the IS is regulated by EB1. (A) LAT-GFP 
dynamics in control and EB1-silenced cells analyzed by TIRFM as in Figure 4A. 
Images were taken every 33 (control) or 51 ms (EB1 KD) at a penetrance of 150 nm. 
A representative cell from out of 4 independent experiments is shown. (B) Analysis of 
LAT-GFP and CD3ζ-Cherry dynamics in control and EB1-silenced cells by TIRFM 
as in Figure 3D. Images were taken every 2s at a penetrance of 250 nm. A single time 
frame is showed, as well as a 3D reconstruction of time vs XY planes. Graph, vesicle 
encounter at the TIRFM plane. Vesicles from 100 time frames were analyzed from 
out of 11 cells for trajectories from 5 different experiments. Images were processed 
for dynamics and co-localization with Imaris software (**, P<0.05; ***, P<0.001; 
two-tailed ANOVA followed by Bonferroni posttest). (C) Co-immunoprecipitation of 
CD3ζ and LAT in control and EB1-silenced cells. Cells were stimulated or not with 
anti-CD3ε+anti-CD28 antibodies.  
 
Figure 6. Signal activation at the IS is regulated by EB1. (A) Western blot 
showing defective LAT activation in EB1-silenced cells CH7C17 or J77 Jurkat T 
cells stimulated with HA-specific peptide or SEE for the indicated times. Graphs, 
mean +/- SEM from 5 and 6 different experiments, respectively (*, P<0.05; **, 
P<0.01. Two-tailed ANOVA followed by Bonferroni posttests) (B-C) Western blots 
showing phosphorylation of CD3ζ (B) and ZAP70 (C) in control and EB1-silenced 
CH7C17 or J77 Jurkat T cells stimulated with HA- or SEE-specific peptide for the 
indicated times. Graphs, mean +/- SEM (differences were considered not significant 
after a two-tailed ANOVA analysis followed by Bonferroni posttests; Y83: N=9 
(HA), N=5 (SEE); Y493: N=4 (HA); N=3 (SEE)). (D) Phosphorylation of CD3ζ and 
LAT in control and EB1-silenced T lymphoblasts plated on anti-CD3+anti-CD28 
antibodies. A representative experiment out of at least 3 independent experiments is 
shown. Graphs, mean +/- SEM from 3 different experiments (*, P<0.05; two-tailed 
ANOVA followed by Bonferroni posttests). 
 
Figure 7. PLCγ1 activation and clustering at the IS depends on EB1. (A) Control 
and EB1-silenced human T lymphoblasts were conjugated with SEE-pulsed Raji 
APCs, fixed and processed for immunofluorescence with the indicated antibodies. 
PLCγ1 activation was detected with the phospho-specific antibody PLCγ1Y783. Bar, 
10 µm. Asterisks mark SEE-pulsed Raji B cells. A representative cell conjugate out of 
at least 3 independent experiments is shown. (B) Scatter plot of the signal ratio for 
PLC1γY783 at the IS compared with the rest of the cell. Means +/- SD from 3 
independent experiments are depicted. Data were analyzed with Mann-Whitney test. 
(C) Western blot showing the effect of EB1 knockdown on the timing of PLCγ1 
Y783 phosphorylation in CH7C17 Jurkat T cells stimulated with HA specific peptide 
and in T lymphoblasts stimulated with SEE (*, P<0.05, ***, P<0.001. Two-tailed 
ANOVA followed by Bonferroni posttests. N=4 (HA) and N=3 (SEE)). 




















